OREXIGEN THERAPEUTICS

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. Its lead combination product candidates include Contrave, which has completed Phase III clinical trials; and Empatic that has completed Phase II clinical trials. Contrave is a combination of two drugs, bupropion and naltrexone, in a sustained release formulation (SR). Bupropion is an antidepressant and smoking cessation medication; naltrexone is ... a treatment for alcohol and opioid addiction. The company's Empatic product candidate is a combination of bupropion SR and zonisamide SR. Zonisamide, in an immediate release formulation for the adjunctive treatment of partial seizures, a form of epilepsy. The company was founded in 2002 and is based in La Jolla, California.

OREXIGEN THERAPEUTICS

Social Links:

Facebook

Industry:

Biotechnology Health Care Pharmaceutical

Founded:

2002-01-01

Address:

La Jolla, California, United States

Country:

United States

Website Url:

http://www.orexigen.com

Total Employee:

101+

Status:

Active

Contact:

(858) 875-8600

Email Addresses:

[email protected]

Total Funding:

301 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF Microsoft Exchange Online Amazon Office 365 Mail IPv6 Microsoft Azure DNS Microsoft Amazon Ohio Region

Similar Organizations

aimmune-therapeutics-logo

Aimmune Therapeutics

Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

salix-pharmaceuticals-logo

Salix Pharmaceuticals

Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.

Current Advisors List

lota-zoth_image

Lota Zoth Non-Executive Member of the Board of Directors @ Orexigen Therapeutics
Board_member

joe-lacob_image

Joe Lacob Member of the Board of Directors @ Orexigen Therapeutics
Board_member

patrick-mahaffy_image

Patrick Mahaffy Board of Director @ Orexigen Therapeutics
Board_member

daniel-turner_image

Daniel Turner Board of Director @ Orexigen Therapeutics
Board_member

michael-narachi_image

Michael Narachi Member of the Board of Directors @ Orexigen Therapeutics
Board_member
2009-03-01

brian-dovey_image

Brian Dovey Board Member @ Orexigen Therapeutics
Board_member

wendy-dixon_image

Wendy Dixon Member of the Board of Directors @ Orexigen Therapeutics
Board_member

Current Employees Featured

michael-narachi_image

Michael Narachi
Michael Narachi President & CEO @ Orexigen Therapeutics
President & CEO
2009-03-01

heather-turner_image

Heather Turner
Heather Turner Senior Vice President, General Counsel & Secretary @ Orexigen Therapeutics
Senior Vice President, General Counsel & Secretary

eckard-weber_image